GENE ONLINE|News &
Opinion
Blog

Region
COVID-19: BioNTech Commences Phase 2 Vaccine Trials in China with Fosun
2020-12-05
Taiwan Kicks off 2020 Healthcare Expo, Targeting Strategies to Boost Digital Transformation in Biopharma Industry
2020-12-03
Two South Korean Companies Look to Capture the Biosimilars Market Worth Billions
2020-12-01
China’s Regulatory Body Accepts Application for First Selective Internal Radiation Therapy for HCC
2020-11-29
Russian Vaccine Makers Nudge AstraZeneca to Combine COVID-19 Vaccine, AZD1222 with Sputnik V
2020-11-28
Ascentage Pharma’s Bcl-2 Inhibitor Enters Clinical Trials in Europe
2020-11-28
China’s NMPA Greenlights LOKELMA Label Update for Haemodialysis, Hyperkalaemia Patients
2020-11-27
Over 1000 Pharma & Biotech players across Asia and beyond to gather virtually in December!
2020-11-27
Medigen Signs Agreement with Metronic, Making it the First Taiwan-made Vaccine Deal
2020-11-26
Connect with the Top 50 Epidemic Prevention Companies from Taiwan
2020-11-26
D3 Bio Launches with $200 Million to Advance Precision Medicine in Oncology and Immunology Space
2020-11-22
Lilly Partners with Samsung Biologics to Boost Delivery of COVID-19 Antibody Treatments
2020-11-19
Celltrion Announces Positive Phase 1 Results for COVID-19 Antibody Therapy
2020-11-12
Insilico’s AI Pipeline for Drug Discovery To Grow with New Partnership
2020-11-11
Xtandi Scores Regulatory Win in China for Non-Metastatic Castration-Resistant Prostate Cancer
2020-11-11
1 27 28 29 30 31 42
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
EVENT
Scroll to Top